Vainshelboim Baruch, Müller Jan, Lima Ricardo M, Nead Kevin T, Chester Cariad, Chan Khin, Kokkinos Peter, Myers Jonathan
Cardiology Division, Veterans Affairs Palo Alto Health Care System/Stanford University, Palo Alto, CA.
Cardiology Division, Veterans Affairs Palo Alto Health Care System/Stanford University, Palo Alto, CA; Institute of Preventive Pediatrics, Technical University of Munich, Department of Pediatric Cardiology and Congenital Heart Disease, German Heart Center, Munich, Germany.
Ann Epidemiol. 2017 Jul;27(7):442-447. doi: 10.1016/j.annepidem.2017.06.003. Epub 2017 Jun 29.
The preventive role of cardiorespiratory fitness (CRF) in cancer is not well established. The present study sought to evaluate the association between CRF and cancer incidence in men.
Maximal exercise testing was performed in 4920 men (59.2 ± 11.4 years) free from malignancy at baseline who were followed for 12.7 ± 7.5 years. Relative risks and population attributable risks were determined.
During the follow-up, 25.8% were diagnosed with any type of cancer. CRF was inversely associated with total cancer incidence; for each one metabolic equivalent increase in CRF, there was a 4% reduction in cancer incidence (P < .001). Compared with low CRF, moderate and high CRF levels were associated with 14% (95% CI [0.74-0.99]) and 26% (95% CI [0.62-0.89]) reduced risks for all cancers, respectively (P for trend = .004). Low CRF had a population attributable risk of 3.0% for cancer incidence. The associations between CRF, prostate, skin and colorectal cancers were not significant.
Higher CRF is associated with lower total cancer incidence in men. A novel finding suggests that eliminating low CRF as a risk factor would potentially prevent considerable cancer morbidity and reduce the societal and economic burden associated with cancer. These findings underscore the importance of CRF for primary cancer prevention.
心肺适能(CRF)在癌症预防中的作用尚未明确。本研究旨在评估男性CRF与癌症发病率之间的关联。
对4920名男性(59.2±11.4岁)进行最大运动测试,这些男性在基线时无恶性肿瘤,随访12.7±7.5年。确定相对风险和人群归因风险。
随访期间,25.8%的男性被诊断患有任何类型的癌症。CRF与癌症总发病率呈负相关;CRF每增加1个代谢当量,癌症发病率降低4%(P<0.001)。与低CRF相比,中、高CRF水平分别与所有癌症风险降低14%(95%CI[0.74-0.99])和26%(95%CI[0.62-0.89])相关(趋势P=0.004)。低CRF对癌症发病率的人群归因风险为3.0%。CRF与前列腺癌、皮肤癌和结直肠癌之间的关联不显著。
较高的CRF与男性较低的癌症总发病率相关。一项新发现表明,消除低CRF作为一个风险因素可能会预防相当数量的癌症发病,并减轻与癌症相关的社会和经济负担。这些发现强调了CRF在原发性癌症预防中的重要性。